AMAG Pharmaceuticals Inc logo

AMAG - AMAG Pharmaceuticals Inc Share Price

$11.84 -0.5  -4.1%

Last Trade - 17/01/20

Sector
Healthcare
Size
Small Cap
Market Cap £308.7m
Enterprise Value £371.4m
Revenue £250.7m
Position in Universe 3208th / 6415
Bullish
Bearish
Unlock AMAG Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

AMAG Revenue Unlock AMAG Revenue

Net Income

AMAG Net Income Unlock AMAG Revenue

Normalised EPS

AMAG Normalised EPS Unlock AMAG Revenue

PE Ratio Range

AMAG PE Ratio Range Unlock AMAG Revenue

Dividend Yield Range

AMAG Dividend Yield Range Unlock AMAG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AMAG EPS Forecasts Unlock AMAG Revenue
Profile Summary

AMAG Pharmaceuticals, Inc. is a pharmaceutical company. The Company's segment is the manufacture, development and commercialization of products and services for use in treating various conditions, with a focus on maternal health, anemia management and cancer supportive care. Its offerings focus on maternal health, anemia management and cancer supportive care, including its product, Makena (hydroxyprogesterone caproate injection); its product, Feraheme (ferumoxytol), for intravenous (IV) use, and MuGard Mucoadhesive Oral Wound Rinse. It is engaged in the development of Digoxin immune fab, a polyclonal antibody for the treatment of severe preeclampsia in pregnant women. Makena is a drug indicated to reduce the risk of preterm birth in women pregnant with a single baby having a history of singleton spontaneous preterm birth.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated November 9, 1981
Public Since June 11, 1986
No. of Shareholders: 8,000
No. of Employees: 467
Sector Healthcare
Industry Pharmaceuticals
Index Nasdaq Composite , S&P 600 Small Cap , S&P Composite 1500 ,
Exchange NASDAQ Global Select Market
Shares in Issue 33,915,766
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AMAG Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AMAG
Upcoming Events for AMAG
Similar to AMAG
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.